Publication: Regenerative Therapies for Diabetic Microangiopathy
Open/View Files
Date
2012
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Hindawi Publishing Corporation
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Bassi, Roberto, Alessio Trevisani, Sara Tezza, Moufida Ben Nasr, Francesca Gatti, Andrea Vergani, Antonio Farina, and Paolo Fiorina. 2012. Regenerative therapies for diabetic microangiopathy. Experimental Diabetes Research 2012:916560.
Research Data
Abstract
Hyperglycaemia occurring in diabetes is responsible for accelerated arterial remodeling and atherosclerosis, affecting the macro- and the microcirculatory system. Vessel injury is mainly related to deregulation of glucose homeostasis and insulin/insulin-precursors production, generation of advanced glycation end-products, reduction in nitric oxide synthesis, and oxidative and reductive stress. It occurs both at extracellular level with increased calcium and matrix proteins deposition and at intracellular level, with abnormalities of intracellular pathways and increased cell death. Peripheral arterial disease, coronary heart disease, and ischemic stroke are the main causes of morbidity/mortality in diabetic patients representing a major clinical and economic issue. Pharmacological therapies, administration of growth factors, and stem cellular strategies are the most effective approaches and will be discussed in depth in this comprehensive review covering the regenerative therapies of diabetic microangiopathy.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service